HARVARD BIOSCIENCE INC — Director's Dealing 2015

Jul 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2015-07-10

Reporting Person: GREEN DAVID (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-10	Common Stock	S	26475	$5.28	Disposed	517178	Direct
2015-07-13	Common Stock	S	10527	$5.29	Disposed	506651	Direct
2015-07-14	Common Stock	S	14595	$5.27	Disposed	492056	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	322124	Indirect
Common Stock	300000	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $5.25 to $5.35. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Includes (a) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (b) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; (c) a deferred stock award of 14,400 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 4, 2015, immediately prior to the commencement of such meeting, and (ii) June 4, 2016; and (d) 446,188 shares of common stock held by the Reporting Person.

F3: This transaction was executed in multiple trades at prices ranging from $5.25 to $5.33. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: Includes (a) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (b) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; (c) a deferred stock award of 14,400 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 4, 2015, immediately prior to the commencement of such meeting, and (ii) June 4, 2016; and (d) 435,661 shares of common stock held by the Reporting Person.

F5: This transaction was executed in multiple trades at prices ranging from $5.25 to $5.30. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: Includes (a) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (b) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; (c) a deferred stock award of 14,400 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 4, 2015, immediately prior to the commencement of such meeting, and (ii) June 4, 2016; and (d) 421,066 shares of common stock held by the Reporting Person.